Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
Clinical trial NCT03031730 · TERMINATED
Trial details
- NCT number
- NCT03031730
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2024-07-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.